Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

5 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$49.70

-1.4%

3.3%

Allied Biotech

Market Cap: NT$2.3b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$24.05

4.3%

37.8%

Bioray Biotech

Market Cap: NT$575.4m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.

7561

NT$17.10

4.0%

-35.0%

TTY Biopharm

Market Cap: NT$18.9b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$76.40

-1.5%

0.3%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$74.20

-0.8%

-0.1%